Inside informationEnglish
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- DBV Technologies
- Filed
- 10/02/2026, 22:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 114062_20260210